Thomas Dittmar

26PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologySolid tumoursCeramics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 26, 2026
Zeb1 Is a Determinant of EMT in Human MDA-MB-231 Breast Cancer Cells and M13-MDA231 Tumor Hybrids.

|Aug 14, 2025
Differential Effects of Snail-KO in Human Breast Epithelial Cells and Human Breast Epithelial × Human Breast Cancer Hybrids.

Silvia Keil, Thomas Dittmar

|Jun 05, 2025
Differential effects of minocycline on human breast epithelial cells, human breast cancer cells and their tumor hybrids.

Fuad Moayed, Silvia Keil, Thomas Dittmar

|Jun 19, 2024
How Much Do You Fuse? A Comparison of Cell Fusion Assays in a Breast Cancer Model.

Mareike Sieler, Jessica Dörnen, Thomas Dittmar

|Dec 23, 2023
Altered Phenotypes of Breast Epithelial × Breast Cancer Hybrids after ZEB1 Knock-Out.

Alexander Merckens, Mareike Sieler, Silvia Keil

|May 29, 2023
Why do certain cancer cells alter functionality and fuse?

Thomas Dittmar, Mareike Sieler, Ralf Hass

Pageof 5

Frequent Collaborators

6 joint publications

Ralf Hass

1 joint publications

Roland Jacobs

1 joint publications

Ola Myklebost

1 joint publications

Claudia Hagedorn